Bausch Health Archives - Kybora

首页
关于我们
我们的服务
最新发布
联系我们
中文
- English
- 中文

首页
关于我们
我们的服务
最新发布
联系我们
中文
- English
- 中文

KYBORA successfully helps Stada license Xlucane to Bausch Health

5月 6, 2020

No comments

News

KYBORA successfully helps Stada license Xlucane to Bausch Health

KYBORA is pleased to announce that it has successfully […]

Recent blog post.

The Impact of the Inflation Reduction Act (IRA) on Orphan Drugs

Posted: 2月 ago
Competition in the Biotech Industry

Posted: 3月 ago
Navigating the Complexities of Market Access and Reimbursement in the US Biotech Industry

Posted: 3月 ago
Navigating Biotech Product Licensing in China: Bridging Opportunity and Complexity

Posted: 3月 ago
Navigating the Complex Intellectual Property Landscape as a Biotech CEO

Posted: 4月 ago

Tags.

#biopharma Licensing Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

我们期待听取您关于业务拓展的需求

KYBORA是一家聚焦创新医药和医疗器械领域的全球化顾问公司。她以帮助客户拓展全球业务并取得卓越业绩为使命，为遍布世界各地的客户提供包括全球产权交易、融资、收并购、资源对接及高端战略咨询在内的优质服务。

关于我们.

关于开博锐
核心团队
成功案例
全球驻地

我们的服务.

收并购
产权交易
融资
战略咨询

最新发布.

The Impact of the Inflation Reduction Act (IRA) on Orphan Drugs

Posted: 2月 ago
Competition in the Biotech Industry

Posted: 3月 ago

© KYBORA All Rights Reserved.

Terms of service | Privacy policy

TYPE & ENTER: